182 filings
Page 5 of 10
8-K
jrbxqk gh
11 Aug 20
Departure of Directors or Certain Officers
4:10pm
8-K
v2c7iy1p
10 Aug 20
Results of Operations and Financial Condition
5:06pm
8-K
u2lsvcg60yxx5fu7g4zn
15 Jul 20
Results of Operations and Financial Condition
5:17pm
8-K
6qc6 2d9x
14 Jul 20
Other Events
4:12pm
8-K
gtmoud8
13 Jul 20
OpGen Subsidiary Curetis GmbH Secures Access to Additional EUR 5.0 Million Non-Dilutive Debt Financing Tranche from EIB
5:24pm
8-K/A
7djncqukvn
15 Jun 20
Combined Statement of Operations and Other Comprehensive Loss
5:07pm
8-K
h9jaonsc7 n4
3 Jun 20
OpGen Expands Partnership with New York State Department of Health and IDC to Detect Antimicrobial-Resistant Infections
4:48pm
8-K
n46xpu87q4so
11 May 20
Other Events
5:16pm
8-K
aut7azde 1vbfpub
7 May 20
OpGen Reports First Quarter 2020 Financial Results and Provides Business Update
4:38pm
8-K
2w32jnmuf0ewvtg29ds
28 Apr 20
Entry into a Material Definitive Agreement
4:46pm
8-K
3rv01q038ojao
16 Apr 20
Other Events
4:15pm
8-K
o0ybcq
14 Apr 20
OpGen Announces Preliminary Unaudited Revenue and Cash Position for First Quarter 2020 and Provides Business Update
5:22pm
8-K
ubmc3tqua2ov
2 Apr 20
Completion of Acquisition or Disposition of Assets
5:30pm
8-K
g8la5
30 Mar 20
OpGen Announces Shareholder Approval for Business Combination with Curetis
4:16pm
8-K
uermo
24 Mar 20
Results of Operations and Financial Condition
5:28pm
8-K
xwqu1hnddhwul y57it
19 Mar 20
OpGen Provides Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis
4:22pm
8-K
9ceastckfncno9iuvwr
16 Mar 20
OpGen Provides Update on Curetis Now Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe
4:09pm
8-K
twz fkvyzfojm52
10 Mar 20
Curetis N.V. Shareholders Approve Planned Business Combination with OpGen
5:29pm
8-K
5xu6sf454lp9ht0
28 Feb 20
Entry into a Material Definitive Agreement
12:00am
8-K
kl4vwwx6vpyzathf7
20 Feb 20
OpGen Provides Update on Curetis Preliminary, Unaudited 2019 Condensed Combined Key Financials and Business Update
5:22pm